Variant report
Variant | nsv599152 |
---|---|
Chromosome Location | chr5:99234733-99303002 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:222)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr5:99235472-99235650 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CBX3 | chr5:99235928-99236722 | HCT-116 | colon: | n/a | n/a |
3 | CEBPB | chr5:99275443-99275530 | K562 | blood: | n/a | chr5:99275488-99275499 |
4 | CEBPB | chr5:99287769-99288059 | HepG2 | liver: | n/a | chr5:99287911-99287922 |
5 | CEBPB | chr5:99280572-99280892 | A549 | lung: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
6 | CEBPB | chr5:99280745-99280940 | H1-hESC | embryonic stem cell: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
7 | CEBPB | chr5:99287782-99288036 | A549 | lung: | n/a | chr5:99287911-99287922 |
8 | CEBPB | chr5:99266393-99266617 | A549 | lung: | n/a | chr5:99266520-99266531 chr5:99266520-99266533 chr5:99266520-99266533 |
9 | CEBPB | chr5:99266376-99266641 | HepG2 | liver: | n/a | chr5:99266520-99266531 chr5:99266520-99266533 chr5:99266520-99266533 |
10 | CEBPB | chr5:99280607-99280936 | IMR90 | lung: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
11 | CEBPB | chr5:99275354-99275668 | IMR90 | lung: | n/a | chr5:99275488-99275499 |
12 | CEBPB | chr5:99275330-99275682 | HepG2 | liver: | n/a | chr5:99275488-99275499 |
13 | CEBPB | chr5:99240558-99240601 | K562 | blood: | n/a | n/a |
14 | CEBPB | chr5:99287763-99288089 | IMR90 | lung: | n/a | chr5:99287911-99287922 |
15 | CEBPB | chr5:99280601-99280858 | HepG2 | liver: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
16 | CEBPB | chr5:99266424-99266615 | K562 | blood: | n/a | chr5:99266520-99266531 chr5:99266520-99266533 chr5:99266520-99266533 |
17 | CEBPB | chr5:99281660-99281902 | A549 | lung: | n/a | chr5:99281715-99281726 chr5:99281776-99281787 |
18 | CEBPB | chr5:99275346-99275667 | A549 | lung: | n/a | chr5:99275488-99275499 |
19 | CEBPB | chr5:99281714-99281914 | HepG2 | liver: | n/a | chr5:99281715-99281726 chr5:99281776-99281787 |
20 | CEBPB | chr5:99235842-99236653 | HCT-116 | colon: | n/a | n/a |
21 | CTCF | chr5:99247720-99247870 | GM12872 | blood: | n/a | n/a |
22 | CTCF | chr5:99247860-99248010 | GM06990 | blood: | n/a | n/a |
23 | CTCF | chr5:99247748-99247867 | MCF-7 | breast: | n/a | n/a |
24 | CTCF | chr5:99287120-99287270 | GM12864 | blood: | n/a | n/a |
25 | CTCF | chr5:99247740-99247890 | HCT-116 | colon: | n/a | n/a |
26 | CTCF | chr5:99247740-99247890 | HRE | kidney: | n/a | n/a |
27 | CTCF | chr5:99247760-99247910 | RPTEC | kidney: | n/a | n/a |
28 | CTCF | chr5:99247720-99247870 | HepG2 | liver: | n/a | n/a |
29 | CTCF | chr5:99247740-99247890 | GM12873 | blood: | n/a | n/a |
30 | CTCF | chr5:99247806-99247866 | GM12878 | blood: | n/a | n/a |
31 | CTCF | chr5:99247740-99247890 | HRPEpiC | eye: | n/a | n/a |
32 | CTCF | chr5:99247609-99248048 | MCF-7 | breast: | n/a | n/a |
33 | CTCF | chr5:99247750-99247906 | MCF-7 | breast: | n/a | n/a |
34 | CTCF | chr5:99247800-99247950 | A549 | lung: | n/a | n/a |
35 | CTCF | chr5:99247700-99247850 | GM12864 | blood: | n/a | n/a |
36 | CTCF | chr5:99247780-99247930 | MCF-7 | breast: | n/a | n/a |
37 | CTCF | chr5:99247720-99247870 | HEK293 | kidney: | n/a | n/a |
38 | CTCF | chr5:99247721-99247816 | LNCaP | prostate: | n/a | n/a |
39 | CTCF | chr5:99247760-99247910 | GM12875 | blood: | n/a | n/a |
40 | CTCF | chr5:99247840-99247990 | HRPEpiC | eye: | n/a | n/a |
41 | CTCF | chr5:99247640-99247790 | BE2_C | brain: | n/a | n/a |
42 | CTCF | chr5:99243793-99243862 | GM10248 | blood: | n/a | n/a |
43 | CTCF | chr5:99247780-99247930 | GM12866 | blood: | n/a | n/a |
44 | CTCF | chr5:99247680-99247830 | RPTEC | kidney: | n/a | n/a |
45 | CTCF | chr5:99247820-99247970 | GM12872 | blood: | n/a | n/a |
46 | CTCF | chr5:99247820-99247825 | LNCaP | prostate: | n/a | n/a |
47 | CTCF | chr5:99247740-99247890 | HEEpiC | esophagus: | n/a | n/a |
48 | CTCF | chr5:99247691-99247992 | GM12878 | blood: | n/a | n/a |
49 | CTCF | chr5:99247720-99247870 | WERI-Rb-1 | eye: | n/a | n/a |
50 | CTCF | chr5:99247800-99247950 | BE2_C | brain: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:99279070..99281321-chr9:113352239..113355129,2 | MCF-7 | breast: | |
2 | chr5:99236316..99237878-chr5:99242234..99244440,2 | MCF-7 | breast: | |
3 | chr5:99281632..99283428-chr5:99288358..99290129,2 | MCF-7 | breast: | |
4 | chr5:99272528..99274253-chr5:99280354..99282185,2 | K562 | blood: | |
5 | chr5:99272528..99274253-chr5:99280354..99282185,2 | K562 | blood: | |
6 | chr5:99236316..99237878-chr5:99242234..99244440,2 | MCF-7 | breast: | |
7 | chr5:99281632..99283428-chr5:99288358..99290129,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250391 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs386690455 | chr5:99235401-99235402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552446954 | chr5:99235408-99235409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564364080 | chr5:99235430-99235431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141818412 | chr5:99235435-99235436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191530410 | chr5:99235490-99235491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550103691 | chr5:99235512-99235513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1477652 | chr5:99235527-99235528 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs150193718 | chr5:99235529-99235530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188486254 | chr5:99235536-99235537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566984823 | chr5:99235548-99235549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534119532 | chr5:99235591-99235592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138778379 | chr5:99235615-99235616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13356795 | chr5:99235642-99235643 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs538119537 | chr5:99235644-99235645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556454263 | chr5:99235659-99235660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574334788 | chr5:99235751-99235752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571965219 | chr5:99235763-99235764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539379226 | chr5:99235764-99235765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369893132 | chr5:99235765-99235766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372595478 | chr5:99235770-99235771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572781742 | chr5:99235781-99235782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541837318 | chr5:99235813-99235814 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559988257 | chr5:99235877-99235878 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17167386 | chr5:99235896-99235897 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs533808741 | chr5:99235924-99235925 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564229053 | chr5:99236028-99236029 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572444917 | chr5:99236035-99236036 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201843514 | chr5:99236079-99236080 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs36049737 | chr5:99236081-99236082 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs61076029 | chr5:99236099-99236100 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs116095454 | chr5:99236145-99236146 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562052192 | chr5:99236154-99236155 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2602989 | chr5:99236162-99236163 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs548613220 | chr5:99236232-99236233 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574057538 | chr5:99236300-99236301 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372520979 | chr5:99236319-99236320 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566759279 | chr5:99236321-99236322 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534248471 | chr5:99236355-99236356 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552273842 | chr5:99236412-99236413 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192284630 | chr5:99236419-99236420 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149381712 | chr5:99236448-99236449 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556416700 | chr5:99236453-99236454 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575124308 | chr5:99236512-99236513 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150286284 | chr5:99236542-99236543 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535095072 | chr5:99236568-99236569 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75063866 | chr5:99236602-99236603 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185296132 | chr5:99236611-99236612 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147492483 | chr5:99236614-99236615 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140483458 | chr5:99236644-99236645 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577507075 | chr5:99236645-99236646 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99235400-99235800 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr5:99235400-99236000 | Enhancers | HUVEC | blood vessel |
3 | chr5:99235400-99236800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr5:99235400-99236800 | Enhancers | Fetal Kidney | kidney |
5 | chr5:99235400-99236800 | Enhancers | NHEK | skin |
6 | chr5:99235400-99237000 | Enhancers | Hela-S3 | cervix |
7 | chr5:99235600-99236800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr5:99235600-99237000 | Enhancers | NH-A | brain |
9 | chr5:99235800-99236000 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
10 | chr5:99236000-99236200 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr5:99236000-99236400 | Flanking Active TSS | HUVEC | blood vessel |
12 | chr5:99236200-99236800 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
13 | chr5:99236400-99237200 | Enhancers | HUVEC | blood vessel |
14 | chr5:99236800-99237600 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr5:99237000-99237400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr5:99241400-99242600 | Enhancers | Fetal Lung | lung |
17 | chr5:99243600-99244400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr5:99247600-99249000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr5:99248600-99250400 | Enhancers | H1 Cell Line | embryonic stem cell |
20 | chr5:99264200-99264400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
21 | chr5:99264400-99265600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
22 | chr5:99265400-99266000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr5:99265600-99265800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
24 | chr5:99281400-99282000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
25 | chr5:99286000-99286200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
26 | chr5:99286000-99287200 | Enhancers | Spleen | Spleen |
27 | chr5:99286200-99293400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |